Stay Current With Your Defense Against Equine Influenza
Don't let new strains make you doubt your horse's disease protection.
January 14, 2015
From AQHA Corporate Partner Zoetis
Equine influenza is a highly contagious respiratory disease that causes fever, coughing and nasal discharge.1 Treating it can cost you money. Recovery can cost you time away from training and competition.
The best method for helping to protect your horse against equine influenza virus is to vaccinate before exposure. But over time, new EIV strains can appear in circulation. So how can you trust that your horse is protected against the current EIV strains?
To support current protection, the World Organisation for Animal Health encourages vaccine manufacturers to work with laboratories that can test for reactivity against the current circulating strains.2
For this reason, Zoetis, manufacturer of the first EIV vaccine, FLUVAC INNOVATOR®, has partnered with the renowned Gluck Equine Research Center at the University of Kentucky.
Equine disorders and illnesses can be scary to deal with. Put your mind at ease with AQHA's "Your Horses Health" DVDs. Loaded with the latest medical information to keep horse owners up-to-date, you'll learn about diseases and disorders including West Nile virus, colic, and numerous others.
Through this research, Zoetis continues its legacy of evaluating the FLUVAC INNOVATOR line of vaccines to help ensure the most relevant protection.3-7 In fact, the FLUVAC INNOVATOR vaccine line sets the standard for equine influenza vaccines with test studies against six EIV strains since 2002.3-7
Most recently, a serologic response study demonstrated an immune response with the FLUVAC INNOVATOR vaccine line against Richmond 07.7 Even though Richmond 07 is not circulating in the United States, it might be a threat to horses with international exposure; therefore Zoetis tested it against the FLUVAC INNOVATOR line of vaccines.
That’s why horse owners can depend on the FLUVAC INNOVATOR line of vaccines, which helps offer demonstrated protection against circulating EIV strains, and know that Zoetis will continue to test and evaluate it.
After all, fever, coughing and nasal discharge aren’t the only causes of discomfort from EIV. There are those lost training days and the additional veterinary costs. In fact, the cost of EIV can reach up to $885 for an unvaccinated horse.*
Learning about diagnosis and therapies of equine diseases is easy with AQHA's "Your Horses Health" DVDs. This series is dedicated to the well-being of your American Quarter Horse and contains the latest medical information from veterinarians.
The American Association of Equine Practitioners recommends vaccinating at-risk horses against EIV every six months.8 At-risk horses include those that are less than 6 years of age, geriatric horses and horses that may be frequently exposed to EIV at shows, trail rides or other events.8
The Zoetis commitment to providing an immunologically current EIV vaccine has made FLUVAC INNOVATOR the most trusted EIV line of vaccines, as well as the market leader.9
To ensure peace of mind, FLUVAC INNOVATOR vaccines are also backed by the Equine Immunization Support Guarantee from Zoetis.† This guarantee provides up to $5,000 for reasonable diagnostic and treatment costs if a horse properly vaccinated by a veterinarian contracts the corresponding equine disease.
For more information on FLUVAC INNOVATOR, contact your veterinarian or visit fluvacinnovator.com. Learn more about other Zoetis equine products at zoetisUS.com.